Edition:
India

Marrone Bio Innovations Inc (MBII.OQ)

MBII.OQ on NASDAQ Stock Exchange Capital Market

1.92USD
1:30am IST
Change (% chg)

$0.09 (+4.92%)
Prev Close
$1.83
Open
$1.84
Day's High
$1.93
Day's Low
$1.83
Volume
90,608
Avg. Vol
159,993
52-wk High
$3.39
52-wk Low
$0.85

Chart for

About

Marrone Bio Innovations, Inc. offers bio-based pest management and plant health products. The Company's bio-based products include naturally occurring microorganisms, such as bacteria, fungi and plant extracts. It sells its products to crop protection market. Its four crop protection products include Regalia, Grandevo, Venerate... (more)

Overall

Beta: 0.29
Market Cap(Mil.): $34.49
Shares Outstanding(Mil.): 31.35
Dividend: --
Yield (%): --

Financials

  MBII.OQ Industry Sector
P/E (TTM): -- 23.47 359.87
EPS (TTM): -1.17 -- --
ROI: -85.16 2.17 10.74
ROE: -- 4.11 13.94

BRIEF-Evogene And Marrone Bio Innovations Announce Phase Advancement In Their Insect Control Collaboration

* EVOGENE AND MARRONE BIO INNOVATIONS ANNOUNCE PHASE ADVANCEMENT IN THEIR INSECT CONTROL COLLABORATION

08 May 2018

BRIEF-Marrone Bio Innovations Appoints Kevin Hammill As New Chief Commercial Officer

* MARRONE BIO INNOVATIONS APPOINTS KEVIN HAMMILL AS NEW CHIEF COMMERCIAL OFFICER Source text for Eikon: Further company coverage:

07 May 2018

BRIEF-Marrone Bio Innovations And Lidorr Chemicals Sign Distribution Agreement In Israel

* MARRONE BIO INNOVATIONS AND LIDORR CHEMICALS LTD. SIGN DISTRIBUTION AGREEMENT IN ISRAEL

26 Apr 2018

BRIEF-Marrone Bio Innovations Announces Proposed Public Offering Of Common Stock

* MARRONE BIO INNOVATIONS, INC. ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

18 Apr 2018

BRIEF-Marrone Bio Innovations Files Prospectus Relates To Offering Of Up To 119 Mln Shares Of Co's Common Stock By Selling Stockholders

* Marrone Bio Innovations Files Prospectus Relates To Offering Of Up To 119 Mln Shares Of Co's Common Stock By Selling Stockholders - SEC Filing Source text (https://bit.ly/2IDKFzU) Further company coverage:

09 Apr 2018

BRIEF-Marrone Bio Innovations Inc Files For Non-Timely 10-K With U.S. SEC

* MARRONE BIO INNOVATIONS INC FILES FOR NON-TIMELY 10-K WITH U.S. SEC Source text: (https://bit.ly/2uJc15x) Further company coverage:

04 Apr 2018

BRIEF-Marrone Bio Innovations Says Q4 Revenue Rose 23.3 Pct To $3.3 Mln

* MARRONE BIO INNOVATIONS, INC. REPORTS RECORD FULL YEAR 2017 FINANCIAL RESULTS

30 Mar 2018

BRIEF-Marrone Bio Innovations Signs Distribution Agreement With Solenis

* MARRONE BIO INNOVATIONS - SIGNS DISTRIBUTION AGREEMENT WITH SOLENIS TO PROVIDE ZEQUANOX MOLLUSCICIDE TREATMENT PROGRAMS FOR WATER SYSTEMS IN U.S., CANADA Source text for Eikon: Further company coverage:

15 Mar 2018

BRIEF-Marrone Bio Innovations Says ‍Board Approved An Increase In Size Of Board To Seven People

* MARRONE BIO INNOVATIONS SAYS ‍ BOARD APPROVED AN INCREASE IN SIZE OF BOARD TO SEVEN PEOPLE - SEC FILING​ Source text: [http://bit.ly/2EthyhL] Further company coverage:

02 Feb 2018

BRIEF-Marrone Bio Announces Stockholder Approval Of Private Placement, Debt Refinance Transactions

* MARRONE BIO INNOVATIONS, INC. ANNOUNCES STOCKHOLDER APPROVAL OF PRIVATE PLACEMENT AND DEBT REFINANCE TRANSACTIONS Source text for Eikon: Further company coverage:

02 Feb 2018

Earnings vs. Estimates